GLAXO
Invest with MTF
Invest Now
Invest in GlaxoSmithKline Pharmaceuticals with 3.24X leverage
Performance
- Low
- ₹2,308
- High
- ₹2,420
- 52 Week Low
- ₹1,921
- 52 Week High
- ₹3,516
- Open Price₹2,382
- Previous Close₹2,380
- Volume86,873
- 50 DMA₹2,485.19
- 100 DMA₹2,586.57
- 200 DMA₹2,653.84
Investment Returns
- Over 1 Month -8.32%
- Over 3 Month -16.14%
- Over 6 Month -25.34%
- Over 1 Year + 9.75%
Smart Investing Starts Here Start SIP with GlaxoSmithKline Pharmaceuticals for Steady Growth!
GlaxoSmithKline Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 41
- PEG Ratio
- 1
- Market Cap Cr
- 39,190
- P/B Ratio
- 22.9
- Average True Range
- 64.58
- EPS
- 56.27
- Dividend Yield
- 1.8
- MACD Signal
- -46.68
- RSI
- 45.19
- MFI
- 45.87
GlaxoSmithKline Pharmaceuticals Financials
GlaxoSmithKline Pharmaceuticals Technicals
EMA & SMA
Current Price
₹2,313.40
-66.8
(-2.81%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹2,400.93
- 50 Day
- ₹2,485.19
- 100 Day
- ₹2,586.57
- 200 Day
- ₹2,653.84
Resistance and Support
2355
- R3 2,520.90
- R2 2,457.20
- R1 2,418.70
- S1 2,316.50
- S2 2,252.80
- S3 2,214.30
GlaxoSmithKline Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
GlaxoSmithKline Pharmaceuticals F&O
About GlaxoSmithKline Pharmaceuticals
- NSE Symbol
- GLAXO
- BSE Symbol
- 500660
- Managing Director
- Mr. B Akshikar
- ISIN
- INE159A01016
Similar Stocks to GlaxoSmithKline Pharmaceuticals
GlaxoSmithKline Pharmaceuticals FAQs
GlaxoSmithKline Pharmaceuticals share price is ₹2,313 As on 23 January, 2026 | 17:33
The Market Cap of GlaxoSmithKline Pharmaceuticals is ₹39190.4 Cr As on 23 January, 2026 | 17:33
The P/E ratio of GlaxoSmithKline Pharmaceuticals is 41 As on 23 January, 2026 | 17:33
The PB ratio of GlaxoSmithKline Pharmaceuticals is 22.9 As on 23 January, 2026 | 17:33
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.